|
1
|
Vartanian AA, Stepanova EV, Gutorov SL,
Solomko ESH, Grigorieva IN, Sokolova IN, Baryshnikov AY and
Lichinitser MR: Prognostic significance of periodic
acid-Schiff-positive patterns in clear cell renal cell carcinoma.
Can J Urol. 16:4726–4732. 2009.PubMed/NCBI
|
|
2
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun D, Sun B, Liu T, Zhao X, Che N, Gu Q,
Dong X, Yao Z, Li R, Li J, et al: Slug promoted vasculogenic
mimicry in hepatocellular carcinoma. J Cell Mol Med. 17:1038–1047.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qin L, Ren Y, Chen AM, Guo FJ, Xu F, Gong
C, Cheng P, Du Y and Liao H: Peroxisome proliferator-activated
receptor γ ligands inhibit VEGF-mediated vasculogenic mimicry of
prostate cancer through the AKT signaling pathway. Mol Med Rep.
10:276–282. 2014.PubMed/NCBI
|
|
5
|
El Hallani S, Boisselier B, Peglion F,
Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL,
Eichmann A, et al: A new alternative mechanism in glioblastoma
vascularization: Tubular vasculogenic mimicry. Brain. 133:973–982.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Francescone RA III, Faibish M and Shao R:
A Matrigel-based tube formation assay to assess the vasculogenic
activity of tumor cells. J Vis Exp. 7:30402011.
|
|
7
|
Zhang Y, Sun B, Zhao X, Liu Z, Wang X, Yao
X, Dong X and Chi J: Clinical significances and prognostic value of
cancer stem-like cells markers and vasculogenic mimicry in renal
cell carcinoma. J Surg Oncol. 108:414–419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sood AK, Fletcher MS, Zahn CM, Gruman LM,
Coffin JE, Seftor EA and Hendrix MJ: The clinical significance of
tumor cell-lined vasculature in ovarian carcinoma: Implications for
anti-vasculogenic therapy. Cancer Biol Ther. 1:661–664. 2002.
View Article : Google Scholar
|
|
9
|
Chen LX, Sun BC, Zhang SW, He YJ, Li XR
and He ZJ: The mechanisms of microenvironments influence on
vasculogenic mimicry between intraocular and subcutaneous melanoma.
Zhonghua Yan Ke Za Zhi. 45:641–646. 2009.In Chinese. PubMed/NCBI
|
|
10
|
Yao LQ, Feng YJ, Ding JX, Jing HM, Xu CJ,
Chen SF, Su M and Yin LH: Characteristics and differentiated
mechanism of vascular endothelial cells-like derived from
epithelial ovarian cancer cells induced by hypoxia. Int J Oncol.
30:1069–1075. 2007.PubMed/NCBI
|
|
11
|
Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J,
Sun T, Wang J, Sun R and Liu Y: Hypoxia promotes vasculogenic
mimicry formation by inducing epithelial-mesenchymal transition in
ovarian carcinoma. Gynecol Oncol. 133:575–583. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Su M, Feng YJ, Yao LQ, Cheng MJ, Xu CJ,
Huang Y, Zhao YQ and Jiang H: Plasticity of ovarian cancer cell
SKOV3ip and vasculogenic mimicry in vivo. Int J Gynecol Cancer.
18:476–486. 2008. View Article : Google Scholar
|
|
13
|
Shih IeM: Trophoblastic vasculogenic
mimicry in gestational choriocarcinoma. Mod Pathol. 24:646–652.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muller CY and Cole LA: The quagmire of hCG
and hCG testing in gynecologic oncology. Gynecol Oncol.
112:663–672. 2009. View Article : Google Scholar
|
|
15
|
Szajnik M, Nowak-Markwitz E, Szczepański
MJ and Spaczyński M: Assessment of expression of luteinizing
hormone (LH)/human chorionic gonadotropin (hCG) receptor (LH/hCGR)
and hCG protein in ovarian cancer tissues. Ginekol Pol. 78:939–943.
2007.In Polish.
|
|
16
|
Lempiäinen A, Stenman UH, Blomqvist C and
Hotakainen K: Free beta-subunit of human chorionic gonadotropin in
serum is a diagnostically sensitive marker of seminomatous
testicular cancer. Clin Chem. 54:1840–1843. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iles RK, Delves PJ and Butler SA: Does hCG
or hCGβ play a role in cancer cell biology? Mol Cell Endocrinol.
329:62–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Burczynska B, Booth MJ, Iles RK, Shah A,
Shiled A and Butler SA: Stable knockdown of hCGβ mRNA expression in
bladder cancer cells results in significant growth inhibition.
Anticancer Res. 33:3611–3614. 2013.PubMed/NCBI
|
|
19
|
Jankowska A, Gunderson SI, Andrusiewicz M,
Burczynska B, Szczerba A, Jarmolowski A, Nowak-Markwitz E and
Warchol JB: Reduction of human chorionic gonadotropin beta subunit
expression by modified U1 snRNA caused apoptosis in cervical cancer
cells. Mol Cancer. 7:262008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jankowska AG, Andrusiewicz M, Fischer N
and Warchol PJ: Expression of hCG and GnRHs and their receptors in
endometrial carcinoma and hyperplasia. Int J Gynecol Cancer.
20:92–101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lenhard M, Tsvilina A, Schumacher L, Kupka
M, Ditsch N, Mayr D, Friese K and Jeschke U: Human chorionic
gonadotropin and its relation to grade, stage and patient survival
in ovarian cancer. BMC Cancer. 12:22012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ziecik AJ, Kaczmarek MM, Blitek A,
Kowalczyk AE, Li X and Rahman NA: Novel biological and possible
applicable roles of LH/hCG receptor. Mol Cell Endocrinol.
269:51–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pietrowski D, Wiehle P, Sator M, Just A
and Keck C: Regulation of the angiopoietin-2 gene by hCG in ovarian
cancer cell line OVCAR-3. Horm Metab Res. 42:328–333. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brouillet S, Hoffmann P, Chauvet S,
Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ and
Alfaidy N: Revisiting the role of hCG: New regulation of the
angiogenic factor EG-VEGF and its receptors. Cell Mol Life Sci.
69:1537–1550. 2012. View Article : Google Scholar
|
|
25
|
Su M, Wei W, Xu X, Wang X, Chen C, Su L
and Zhang Y: Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian
cancer cell line. Int J Gynecol Cancer. 21:1366–1374. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Seftor EA, Meltzer PS, Kirschmann DA,
Margaryan NV, Seftor RE and Hendrix MJ: The epigenetic
reprogramming of poorly aggressive melanoma cells by a metastatic
microenvironment. J Cell Mol Med. 10:174–196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao N, Sun BC, Sun T, Ma YM, Zhao XL, Liu
ZY, Dong XY, Che N, Mo J and Gu Q: Hypoxia-induced vasculogenic
mimicry formation via VE-cadherin regulation by Bcl-2. Med Oncol.
29:3599–3607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gebauer G, Mueller N, Fehm T, Berkholz A,
Beck EP, Jaeger W and Licht P: Expression and regulation of
luteinizing hormone/human chorionic gonadotropin receptors in
ovarian cancer and its correlation to human chorionic
gonadotropin-doxorubicin sensitivity. Am J Obstet Gynecol.
190:1621–1628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun Q, Zou X, Zhang T, Shen J, Yin Y and
Xiang J: The role of miR-200a in vasculogenic mimicry and its
clinical significance in ovarian cancer. Gynecol Oncol.
132:730–738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Elzarrad K, Haroon A, Reed D and Al-Mehdi
AB: Early incorporated endothelial cells as origin of metastatic
tumor vasculogenesis. Clin Exp Metastasis. 26:589–598. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Michel RM, Aguilar JL and Arrieta O: Human
chorionic gonadotropin as an angiogenic factor in breast cancer
during pregnancy. Med Hypotheses. 68:1035–1040. 2007. View Article : Google Scholar
|
|
32
|
Phan B, Rakenius A, Pietrowski D,
Bettendorf H, Keck C and Herr D: hCG-dependent regulation of
angiogenic factors in human granulosa lutein cells. Mol Reprod Dev.
73:878–884. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lempiäinen A, Hotakainen K, Blomqvist C,
Alfthan H and Stenman UH: Hyperglycosylated human chorionic
gonadotropin in serum of testicular cancer patients. Clin Chem.
58:1123–1129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Crabb SJ, Sharp A, Head J, Chau C, Wheater
M, Geldart TR, et al: Investigating serum β-HCG as an independent
prognostic factor in patients (pts) receiving chemotherapy (Ct) for
transitional cell carcinoma (TCC) of the urothelial tract. J Clin
Oncol. 31:45492013.
|
|
35
|
Sun W, Shen ZY, Zhang H, Fan YZ, Zhang WZ,
Zhang JT, Lu XS and Ye C: Overexpression of HIF-1α in primary
gallbladder carcinoma and its relation to vasculogenic mimicry and
unfavourable prognosis. Oncol Rep. 27:1990–2002. 2012.PubMed/NCBI
|
|
36
|
Comito G, Calvani M, Giannoni E, Bianchini
F, Calorini L, Torre E, Migliore C, Giordano S and Chiarugi P:
HIF-1α stabilization by mitochondrial ROS promotes Met-dependent
invasive growth and vasculogenic mimicry in melanoma cells. Free
Radic Biol Med. 51:893–904. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
McCann GA, Rath KS, Naidu S, Lata P,
Hemant B, Sudhakar M, Hideg K, Houghton P, Kuppusamy P, Cohn DE, et
al: HO-3867, is selectively cytotoxic to ovarian cancer cells
through a dual mechanism of action involving the STAT3 and AKT
pathways. Cancer Res. 73(Suppl 8): 10392013. View Article : Google Scholar
|
|
38
|
Yang J, Zhang Y, Wang H, Gao Z, Wang Z,
Liu B, Zhang X, Du M, Huang X, Xu M, et al: Vaccination with the
repeat β-hCG C-terminal peptide carried by heat shock protein-65
(HSP65) for inducing antitumor effects. Tumour Biol. 33:1777–1784.
2012. View Article : Google Scholar : PubMed/NCBI
|
